definiens: means the date first given above ; 1.5 1.1.5 shall mean G$K BIO or RGI as the context requires and shall mean both [COMPANY] BIO and RGI ; 1.6 and words signifying persons shall be construed as to include individuals, firms, bodies corporate, joint ventures, governments, states or · agencies of state or any undertaking ( whether or not having separate legal personality and irrespective of the jurisdiction in or under the laws of which it was incorporated or exists ) ; 1.7 shall mean the proviSion of the Services pursuant to this Agreement and the evaluation by the Parties of whether to add other projects and services to this Agreement ; 1.8 shall mean employees and sub - contractors involved in providing the Services and named in the relevant Schedule or otherwise agreed to in writing by [COMPANY] BIO ; 1.9 means the services to be provided by RGI pursuant to this Agreement at the request of [COMPANY] BIO ( as amended from time to time in accordance with the provisions of this Agreement ) and such other services as may from time to time be agreed upon by RGI and [COMPANY] BIO, including Testing Services, consultation and tissue storage, in connection with this Agreement and as further detailed and agreed upon in a SOW pursuant to Article 1 below ; G:\ CONTRATISERVICESIResponse Genetics -exec.doc • RR Page 4 of 40 CONFIDENTIAL TREATMENT REQUESTED 1.10 means that this Agreement shall commence on the Effective Date and shall continue until the 31 . December 2010 or until the completion of the recruitment phase of [COMPANY] 810 's 11/ clinical trial entitled " erapy Inpatients with MAGE - A3 - positive non - small cell lung Icancer .1 whichever is later, unless sooner . terminated in accordance with the provisions hereof and 1.11 means RGI 's business, among other things, of conducting molecular - based tumor tissue profiling using a proprietary and patented process developed by RGI which involves a complex molecular analysis of specific molecular markers that provides valuable tumor specific gene expression information obtained from a paraffin preserved fresh or frozen tissue sample, which can help the physician choose the most appropriate therapy for a patient prior to starting treatment or assist a pharmaceutical company in identifying the appropriate candidate patient population suitable for a therapy in development